Ferritin-a promising biomarker in MASLD

Heinz Zoller^{1

2}, Herbert Tilg³

Affiliations

¹ Department of Medicine I, Gastroenterology, Hepatology, Endocrinology and Metabolism, Medical University of Innsbruck, Innsbruck, Tirol, Austria heinz.zoller@i-med.ac.at.
² Christian Doppler Laboratory on Iron and Phosphate Biology, Christian Doppler Forschungsgesellschaft, Innsbruck, Tirol, Austria.
³ Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology & Metabolism, Medizinische Universitat Innsbruck, Innsbruck, Tirol, Austria.

Comment

Heinz Zoller et al. Gut. 2024.

. 2024 Apr 5;73(5):720-721.

doi: 10.1136/gutjnl-2023-331848.

Heinz Zoller^{1

2}, Herbert Tilg³

¹ Department of Medicine I, Gastroenterology, Hepatology, Endocrinology and Metabolism, Medical University of Innsbruck, Innsbruck, Tirol, Austria heinz.zoller@i-med.ac.at.
² Christian Doppler Laboratory on Iron and Phosphate Biology, Christian Doppler Forschungsgesellschaft, Innsbruck, Tirol, Austria.
³ Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology & Metabolism, Medizinische Universitat Innsbruck, Innsbruck, Tirol, Austria.

No abstract available

Keywords: FATTY LIVER; FIBROSIS; IRON METABOLISM.

Conflict of interest statement

Competing interests: HT is an Editor of Gut.

Serum ferritin levels can predict long-term outcomes in patients with metabolic dysfunction-associated steatotic liver disease.
Armandi A, Sanavia T, Younes R, Caviglia GP, Rosso C, Govaere O, Liguori A, Francione P, Gallego-Duràn R, Ampuero J, Pennisi G, Aller R, Tiniakos D, Burt A, David E, Vecchio F, Maggioni M, Cabibi D, McLeod D, Pareja MJ, Zaki MYW, Grieco A, Stål P, Kechagias S, Fracanzani AL, Valenti L, Miele L, Fariselli P, Eslam M, Petta S, Hagström H, George J, Schattenberg JM, Romero-Gómez M, Anstee QM, Bugianesi E. Armandi A, et al. Gut. 2024 Apr 5;73(5):825-834. doi: 10.1136/gutjnl-2023-330815. Gut. 2024. PMID: 38199805